NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 874 filers reported holding NOVARTIS A G in Q3 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $16,000 | 0.0% | 188 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $16,000 | +6.7% | 188 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $15,000 | -11.8% | 188 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $17,000 | -32.0% | 188 | -45.2% | 0.00% | -76.9% |
| Q1 2017 | $25,000 | 0.0% | 343 | 0.0% | 0.01% | -7.1% |
| Q4 2016 | $25,000 | -7.4% | 343 | 0.0% | 0.01% | -17.6% |
| Q3 2016 | $27,000 | -3.6% | 343 | 0.0% | 0.02% | -15.0% |
| Q2 2016 | $28,000 | -77.8% | 343 | -80.3% | 0.02% | -78.9% |
| Q1 2016 | $126,000 | +320.0% | 1,743 | +408.2% | 0.10% | +295.8% |
| Q4 2015 | $30,000 | -6.2% | 343 | 0.0% | 0.02% | -17.2% |
| Q3 2015 | $32,000 | -68.9% | 343 | -68.8% | 0.03% | -68.8% |
| Q3 2014 | $103,000 | +4.0% | 1,098 | 0.0% | 0.09% | +5.7% |
| Q2 2014 | $99,000 | -77.3% | 1,098 | -78.6% | 0.09% | -77.3% |
| Q1 2014 | $436,000 | +425.3% | 5,136 | +394.3% | 0.39% | +462.3% |
| Q4 2013 | $83,000 | – | 1,039 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |